Cargando…

Cellular repair factors influencing radiocurability of human malignant tumours.

We have studied the repair of X-ray-induced, potentially lethal damage (PLD) in 9 human tumour lines derived from tumours of varying radiocurability. Cells derived from 3 tumours considered non-radiocurable (1 osteosarcoma, 2 melanoma) repaired significantly more X-ray PLD than cells from 3 tumours...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weichselbaum, R. R., Schmit, A., Little, J. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1982
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010946/ https://www.ncbi.nlm.nih.gov/pubmed/7059452

Ejemplares similares

The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process.
por: Weichselbaum, R. R., et al.
Publicado: (1982)

The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability
por: Widel, M, et al.
Publicado: (1999)

Radiobiology of the C3H Mouse Mammary Carcinoma: The Effect of Body Dose on the Radiocurability of the Tumour Treated In Situ
por: Cohen, A., et al.
Publicado: (1953)

Prediction of radiosensitivity and radiocurability using a novel supervised artificial neural network
por: Zeng, Zihang, et al.
Publicado: (2022)

Further Observations on Radiocurability of a Solid Ehrlich Tumour and Tissue Reactions in the Mouse with Fractionated Radiation Doses and the Effects of Oxygen
por: van den Brenk, H. A. S., et al.
Publicado: (1963)

Effect of Single and Fractionated Doses of X-rays on Radiocurability of Solid Ehrlich Tumour and Tissue Reactions In Vivo, for Different Oxygen Tensions
por: van den Brenk, H. A. S., et al.
Publicado: (1962)

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability()
por: Alfonso, Juan C.L., et al.
Publicado: (2021)

Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy.
por: Weichselbaum, R., et al.
Publicado: (1984)

The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines
por: Schwartz, J L, et al.
Publicado: (1999)

Case of Malignant Fibre-Cellular Tumour Involving the Ileum
por: Buchanan, A. B.
Publicado: (1864)

Influencing factors of depressive symptoms in patients with malignant tumour
por: Wang, Dongmei, et al.
Publicado: (2021)

DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy.
por: Schwartz, J. L., et al.
Publicado: (1996)

A new indicator of human malignant tumour.
por: Metcalfe, S., et al.
Publicado: (1984)

Effect of radiation on nuclear phosphorylation in human malignant tumours.
por: Fahmy, A. R., et al.
Publicado: (1965)

Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
por: Holden, S. A., et al.
Publicado: (1987)

Cellular immunity in human malignant melanoma and melanoma histology.
por: Cameron-Mowat, D. E., et al.
Publicado: (1973)

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours
por: Parliament, M B, et al.
Publicado: (2000)

Cells bearing Fc receptors in human malignant solid tumours.
por: Svennevig, J. L., et al.
Publicado: (1982)

Malignant tumours in Malaya.
por: Ahluwalia, H. S., et al.
Publicado: (1966)

p52 signaling promotes cellular senescence
por: Bernal, Giovanna M., et al.
Publicado: (2022)

Ubiquitin immunoreactivity in human malignant tumours.
por: Ishibashi, Y., et al.
Publicado: (1991)

The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.
por: Musk, S. R., et al.
Publicado: (1990)

Proceedings: Factors influencing the establishment of human tumour cells as a xenograft.
por: Cobb, L. M., et al.
Publicado: (1974)

Influence of tumour size on human prostate tumour metastasis in athymic nude mice.
por: Ware, J. L., et al.
Publicado: (1985)

A serum factor with potential as a tumour marker in malignant lymphoma.
por: Begent, R. H., et al.
Publicado: (1980)

DNA damage and repair in tumour and non-tumour tissues of mice induced by nicotinamide.
por: Olsson, A. R., et al.
Publicado: (1996)

NMR in cancer, XIII: application of the NMR malignancy index to human mammary tumours.
por: Goldsmith, M., et al.
Publicado: (1978)

Cellular distribution of monoclonal antibody in human tumours after i.v. administration.
por: Moshakis, V., et al.
Publicado: (1981)

The Production of Malignant Tumours by Cobalt in the Rat: Intrathoracic Tumours
por: Heath, J. C., et al.
Publicado: (1962)

The influence of tumour burden and therapy on cellular cytotoxicity responses in patients with ocular and skin melanoma.
por: Unsgaard, B., et al.
Publicado: (1975)

Differential expression of translation-associated genes in benign and malignant human breast tumours.
por: Adams, S. M., et al.
Publicado: (1992)

Cellular heterogeneity in tumours.
por: Woodruff, M. F.
Publicado: (1983)

Primary Malignant Tumours of Bone Following Previous Malignancy
por: Patton, J. T., et al.
Publicado: (2008)

The influence of human serum on the anti-tumour activity of two L-asparaginases.
por: Lee, M. B., et al.
Publicado: (1969)

Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.
por: Atkin, N. B., et al.
Publicado: (1979)

Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study
por: Santos, Andreia A, et al.
Publicado: (2013)

Malignant tumours of the salivary glands
por: Bensadoun, R J, et al.
Publicado: (2001)

Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy.
por: Mir, L. M., et al.
Publicado: (1998)

Nuclear magnetic resonance in cancer, XII: Application of NMR malignancy index to human lung tumours.
por: Goldsmith, M., et al.
Publicado: (1977)

The in vivo malignant transformation of mouse fibroblasts in the presence of human tumour xenografts.
por: Sparrow, S., et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_dkdfs1vq02b8g8oto15m1rella